Gufic Bio recommends 10% final dividend for FY26

Gufic Biosciences Ltd's Board of Directors, in its meeting held on May 29, 2026, recommended a final dividend of 10%, which is Re. 0.10 per equity share with a face value of Re. 1 each, for the financial year ended March 31, 2026. The dividend is subject to the approval of shareholders at the upcoming Annual General Meeting and will be paid within the statutory timelines as per the Companies Act, 2013. The board meeting commenced at 7:30 p.m. and concluded at 9:05 p.m.